Speakers

See all speakers of this edition

Program

Link to the complete program (interactive)

Online registration

Attendee's list

Sponsors

Meet the sponsors and collaborators of this edition

General information

Useful information about the symposium

Contact

Organization and technical secretariat

LIVE STREAMING

All sessions of the 10th Forum on Translational Immunology and Cancer Immunotherapy.

After entering your email in the login box, you will be able to view the live streaming of each day of the Forum at the time indicated in the program. Each session corresponds to one Forum day. You should login to view the live streaming for each session. Note that there is also a chatbox to ask questions directly to the speakers; questions will be answered (to the greatest extent possible) during the discussions of each panel.

The next session will begin in:

March 14th, 2024

View Event Go to schedule

March 15th, 2024

View Event Go to schedule

March 16th, 2024

View Event Go to schedule

Welcome to the website of FIT Cancer 10!

The Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) is a non-profit scientific association that brings together researchers and clinicians whose common interest is tumor immunology and cancer immunotherapy. GÉTICA's primary objectives include promoting translational and clinical research, and disseminating and developing educational programs in the fields of immunotherapy and advanced biotherapies in cancer.

We are excited to present the 10th Symposium on Translational Immunology and Cancer Immunotherapy (FIT Cancer 10), the most important national event in the field of tumor immunology and cancer immunotherapy, which will be held at the NH Collection Sevilla hotel from March 14th to 16th, 2024.

Our overall aim is to promote training and continuing education in this field. Thus, we have developed a program that is fundamentally practical at a high level of scientific quality, in the fields of immunology and immunotherapy as applied to cancer; this program will have the endorsement of different scientific societies and organizations. As in previous editions, FIT Cancer 10 will bring together leading clinical specialists and expert researchers in immuno-oncology, from both Spanish and international institutes, to lead the different sessions and presentations that highlight the latest advances in the field. As immunotherapy and immunobiological therapies have become fundamental tools for addressing cancer, FIT Cancer 10—characterized by its transversal and multidisciplinary nature—will be one of the most relevant annual symposiums in Oncology in Spain.

This Symposium is aimed at oncologists, immunologists, and other medical specialists, as well as pharmacists and researchers with an interest in cancer immunology and immunotherapies. It will also provide an excellent training opportunity for the pharmaceutical industry, given the global nature of its contents.

We therefore invite you to take part in FIT Cancer 10, which we are sure will be a great success, given the medical needs in this field. We are convinced that sharing our experiences, as well as updating our knowledge in a symposium with recognized experts, will have a positive impact on our ability to treat this population of patients with immunotherapy.

Please do not hesitate to contact us for additional information or with any questions.

With best regards,

Dra. Ana Arance Fernández. GÉTICA President

Dr. Luis de la Cruz Merino. GÉTICA Vicepresident

Organizing committee of FIT Cancer 10

Dra. Ana Arance Fernández

Hospital Clínic de Barcelona, Barcelona

Dr. Luis de la Cruz Merino

Hospital Universitario Virgen Macarena, Sevilla

Dr. Delvys Rodríguez Abreu

Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria

Dr. Luis Álvarez Vallina

Hospital Universitario 12 de Octubre, Madrid

Dr. Manel Juan Otero

Hospital Clínic de Barcelona, Barcelona

Dr. Antonio J. Conde Moreno

Hospital Universitari i Politècnic La Fe, Valencia

Dra. Elisabeth Pérez Ruiz

Hospital Regional Universitario de Málaga , Málaga

Dr. Xabier Mielgo Rubio

Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid

Scientific committee

Dra. Ana Arance Fernández

Medical Oncology Department. Hospital Clínic de Barcelona. Barcelona

Dr. Luis de la Cruz Merino

Medical Oncology Department. Hospital Universitario Virgen Macarena. Sevilla

Dr. Lorenzo Galluzzi

Department of Radiation Oncology Weill Cornell Medical College New York, USA

Dr. Francisco Aya Moreno

Medical Oncology Department. Hospital Clínic de Barcelona. Barcelona

This website does not collect or transmit personal data of users without their knowledge, and uses its own cookies only for technical purposes. More Information   Accept